Dr. Rowe received his B.S. in Biology from Brandeis University and his PhD in Molecular, Cellular and Developmental Biology from Yale University. Dr. Rowe is a currently an Assistant Professor in Medicine in the Cardiovascular Division at the University of Alabama at Birmingham. The research interest of Dr. Rowe’s laboratory focuses on understanding the molecular pathways that influence mitochondrial metabolism in response to diet and exercise, in order to improve mitochondrial function and reduce the deleterious effects 5of the metabolic syndrome. Specifically, the lab studies the PGC-1 family of transcriptional coactivators and the molecular pathways they regulate in both skeletal and cardiac muscle to maintain normal mitochondrial function (including biogenesis, oxidative capacity and dynamics) and normal metabolic function.
Glenn C. Rowe
University of Alabama at Birmingham